CLASSIFICATION OF CUTANEOUS MALIGNANCIES. 1- PREMALİGNANCİES (in situ) Actinic keratosis Actinic keratosis Bowen’s disease Bowen’s disease Lentigo maligna.

Slides:



Advertisements
Similar presentations
Detection and Treatment of Non-Melanoma Skin Cancers
Advertisements

Skin Pre-Cancer and Cancer
SQUAMOUS CELL CARCINOMA
NonMelanoma Skin Cancer Dr David Burdon-Jones Consultant Dermatologist Dorset County Hospital Foundation Trust Interactive.
Skin Cancer Sarah Boyce Sawyer, MD Dermatology & Laser of Alabama.
Nonmelanoma Skin Tumor
Eyelid Cancer and Reconstruction
Rob Sheehan-Dare Leeds Centre for Dermatology
National Specialist Dermatopathology EQA Scheme Circulation A.
MALIGNANT EYELID TUMOURS
SKIN TUMORS (except malignant melanoma)
Skin tumors & nevi By: Dr. Kazhan Ali Tofiq Kadir Dr. Kazhan Ali Tofiq Kadir April 2014 April 2014.
Skin Tumors Benign and Malignant
Psoriasis & Skin Cancer
Skin Cancer Carlos Garcia MD Dermatology at OUHSC No conflicts of interest to disclose.
Psoriasis and Skin Cancer Edward Pritchard. Long Cases You could get these! Last year’s finals! - Patient with recurrent SCC, with no symptoms. History.
Skin(epidermal) tumors
دکتر سید امیر فرزام عضو هیئت علمی دانشگاه علوم پزشکی قزوین
PATHOLOGY OF THE SKIN 2. Tumours of the skin Máirín E. McMenamin MB MRCPI FRCPath Dip (Dermatopathol) RCPath St. James’s Hospital and University of Dublin,
Skin Tumors By Dr. Alaa A. Naif April 19, 2015
Your Skin J. C. DiGiacomo, M.D., FACS Department of Surgery CentraState Medical Center.
EPITHELIAL PRECANCEROUS SKIN LESIONS BY DR. MAHESH MATHUR MD.DVD,DCP
Terminology of Neoplasms and Tumors  Neoplasm - new growth  Tumor - swelling or neoplasm  Leukemia - malignant disease of bone marrow  Hematoma -
Skin Cancer Incidence Over 1 million new cases of BCC & SCC
A Primer on Skin Cancers Cathryn Zhang, MD University of Arizona 3/8/14.
WELCOME! Primary Care Update: A Practical Approach to Common Problems 1.
SKIN CANCER KARINA PARR, MD RONALD GRIMWOOD, MD KARA KENNEY.
Cutaneous Malignancies
GERIATRIC DERMATOLOGY BY Girija charugundla. MD. SKIN CHANGES Intrinsic factors- decreased rate of epidermal turnover. Decreased activity of melanocytes,
The normal histologic appearance of the skin
Cancer of skin of face and lips: histological structure, clinical forms, stages, precancers diseases and prevention by complication, precancers diseases.
The Pathology of Anal Neoplasia Dr Bryan F Warren Consultant Gastrointestinal Pathologist, Honorary Senior Lecturer and Fellow of Linacre College, Oxford.
S KIN C ANCER Kathy Sheriff, RN, BSN. S KIN C ANCER One in five Americans Crucial risk factor—over exposure to UV radiation in sunlight Other cases, frequent.
C&H Skin Cancer Referral Pathway 2013 Dr Sara Ritchie CCG GP Dermatology Lead.
DR. OLGA WATKINS November Outline Of Presentation Common Skin Lesions, Benign And Malignant Assessment Of Pigmented Lesion Points to take home.
Basal Cell Carcinoma. Basal Cell Carcinoma Basal Cell Carcinoma.
Skin Cancer Overview ; The Challenge of Diagnosing Older Patients Wendy E. Roberts MD.
Vulvar Cancer Women’s Hospital,School of Medicine Zhejiang University.
Skin tumors. Melanocytic naevi Melanocytic naevi are normal, benign proliferations of melanocytes. Although the risk of a naevus evolving into a melanoma.
Cancer Invasive cellular neoplasm that has the capability of spreading throughout the body or body parts; uncontrolled cell growth.
Chapter 111: Cutaneous Neoplasms
Molluscum Contagiosum Yazid Molluscum Contagiosum A self limited cutaneous infection caused by a large DNA poxvirus that affects both children.
Common MMalignant Skin Tumours, M elanoma, Biopsy M ethods, Surgical
VULVA.
MSS Pathology SECTION VI SKIN TUMORS Dr. Mohammed Alorjani MD, EBP
INTEGUMENTARY SYSTEM Chapter 5. ©2004 Delmar Learning, a Division of Thomson Learning, Inc. FUNCTIONS OF THE SKIN The skin has 7 functions: –Covers underlying.
Krisinda C. Dim-Jamora, MD, FPDS Section of Dermatology, The Medical City Department of Dermatology, Makati Medical Center Skin and Cancer Foundation,
Basal Cell Carcinoma Omar Abdullah 1.
MALIGNANT MELANOMA. Outline Introduction Aetiology Types Invasion and Metastasis Risk Factors Diagnosis and Staging Treatment and Prevention.
Skin cancer: Fundamentals of diagnosis and treatment Surgical training meeting, Worcester,6 th September 2017 Simon De Vos, FRCS MRCGP Specialty Dr,
“Malignant skin tumors”
Skin and Soft-Tissue Lesions
MALIGNANT MELANOMA.
INFECTIONS Allergies, Fungal, Bacterial, Viral, Infection, Inflammation, and Genetic.
Skin Cancer 高雄長庚醫院放射腫瘤科 許軒之.
Seborrheic keratosis eyelid
Psoriasis and Skin Cancer
SKIN CANCER.
Pathophysiology Unregulated cell growth and uncontrolled cell division result in the development of neoplasm.  Basal cell keratinization causes basal cells,
Epithelial dysplasia → SCCIS → SCC
Lecture #2 Common Skin Lesions and Skin Malignancies
SKIN NEOPLASM (OVERVIEW)
Principles and Practice of Radiation Therapy
Presentation transcript:

CLASSIFICATION OF CUTANEOUS MALIGNANCIES

1- PREMALİGNANCİES (in situ) Actinic keratosis Actinic keratosis Bowen’s disease Bowen’s disease Lentigo maligna Lentigo maligna Keratinocyte Keratinocyte Melanocyte Melanocyte

2- COMMON CUTANEOUS MALİGNANCİES Basal cell carcinoma Basal cell carcinoma Squamous cell carcinoma Squamous cell carcinoma Keratoacanthoma Keratoacanthoma Debatable ( follicular keratinocyte, basal keratinocyte, primary germ cell ) Debatable ( follicular keratinocyte, basal keratinocyte, primary germ cell ) Keratinocyte Keratinocyte Follicular keratinocyte Follicular keratinocyte

3- MELANOMAS Malignant melanoma Malignant melanoma Lentigo maligna melanoma Lentigo maligna melanoma Melanocyte Melanocyte

4- UNCOMMON CUTANEOUS MALİGNANCİES Sweat gland carcinomas Sweat gland carcinomas Follicular carcinomas Follicular carcinomas Extramammary Paget’s disease Extramammary Paget’s disease Merkel cell carcinoma Merkel cell carcinoma Atypical fibroxanthoma Atypical fibroxanthoma Dermatofibrosarcoma protuberans Dermatofibrosarcoma protuberans Fibrosarcoma Fibrosarcoma Angiosarcoma Angiosarcoma Kaposi’s sarcoma Kaposi’s sarcoma Hemangiopericytoma Hemangiopericytoma Malignant peripheral nerve sheath tms Malignant peripheral nerve sheath tms Liposarcoma Liposarcoma Apocrine or eccrine sweat gland / duct Apocrine or eccrine sweat gland / duct Follicular epithelial cells Follicular epithelial cells Unknown- apocrine Unknown- apocrine Fibroblast or dermal dendrocyte Fibroblast or dermal dendrocyte Fibroblast Fibroblast Endothelial cell Endothelial cell Pericyte Pericyte Schwann cells Schwann cells Lipocyte Lipocyte

COMMON CUTANEOUS MALİGNANCİES Primary cutaneous cancers are classified on the basis of their cell of origin within the skin. They originate most commonly in the epidermal germinative keratinocytes or adnexal structures (e.g.,sweat apparatus, hair follicle).The two principal cutaneous epithelial cancers(nonmelanoma skin cancers- NMSC-) are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).

SQUAMOUS CELL CARCINOMA (SCC) Malignant tumour of keratinocytes, arising in the epidermis, skin appendages, and other stratified squamous mucosa. Malignant tumour of keratinocytes, arising in the epidermis, skin appendages, and other stratified squamous mucosa. SCC usually arises in epidermal precancerous lesions SCC usually arises in epidermal precancerous lesions The majority of UVR-induced lesions have a low rate of distant metastasis in otherwise healty individuals. The majority of UVR-induced lesions have a low rate of distant metastasis in otherwise healty individuals. More aggressive SCC occur in immunosuppressed individuals with a greater incidence of metastasis. More aggressive SCC occur in immunosuppressed individuals with a greater incidence of metastasis.

SCC (2) SCC (2) Etiology: Ultraviolet radiation (sunlight, phototherapy), Human Papillomavirus (HPV), Immunosuppression, Chronic inflammation ( DLE, chronic ulcers, burn scars, chronic radiation dermatitis, lichen planus of oral mucosa), Industrial Carcinogens (Pitch, tar, crude paraffin oil, fuel oil, creosote, nitrosureas), Inorganic arsenic. Etiology: Ultraviolet radiation (sunlight, phototherapy), Human Papillomavirus (HPV), Immunosuppression, Chronic inflammation ( DLE, chronic ulcers, burn scars, chronic radiation dermatitis, lichen planus of oral mucosa), Industrial Carcinogens (Pitch, tar, crude paraffin oil, fuel oil, creosote, nitrosureas), Inorganic arsenic. Differential diagnosis: Any persistent nodule, plaque, or ulcer, but especially when these occur in sun-damaged skin, on the lower lips, in areas of radiodermatitis, in old burn scars, or on the genitalia. Keratoacanthoma may be clinically indistinguishable from differentiated SCC. Differential diagnosis: Any persistent nodule, plaque, or ulcer, but especially when these occur in sun-damaged skin, on the lower lips, in areas of radiodermatitis, in old burn scars, or on the genitalia. Keratoacanthoma may be clinically indistinguishable from differentiated SCC. Course and prognosis: Significant potential for metastasis; metastases are directed to regional lymph nodes. SCC in the skin has an overall metastatic rate of 3 to 4%. Cancers arising in chronic osteomyelitis sinus tracts, in burn scars, and in sites of radiation dermatitis have a metastatic rate of 31, 20, and 18 %, respectively. Course and prognosis: Significant potential for metastasis; metastases are directed to regional lymph nodes. SCC in the skin has an overall metastatic rate of 3 to 4%. Cancers arising in chronic osteomyelitis sinus tracts, in burn scars, and in sites of radiation dermatitis have a metastatic rate of 31, 20, and 18 %, respectively. High-risk SCCs: Diameter > 2 cm, depth > 4 mm, inolvement of bone, muscle, and nerve, location on ear, lip and genitalia, tumors arising in a scar or following ionizing radiation, highly dedifferentiated tumours, in immunosuppressed patients. High-risk SCCs: Diameter > 2 cm, depth > 4 mm, inolvement of bone, muscle, and nerve, location on ear, lip and genitalia, tumors arising in a scar or following ionizing radiation, highly dedifferentiated tumours, in immunosuppressed patients. Management: Surgery, radiotherapy Management: Surgery, radiotherapy

SCC IN SITU (SCCIS) SCCIS is most common caused by UVR or HPV infection, presenting as solitary or multiple macules, papules, or plaques, which may be scaling or hyperkeratotic. SCCIS is most common caused by UVR or HPV infection, presenting as solitary or multiple macules, papules, or plaques, which may be scaling or hyperkeratotic. SCCIS commonly arises in epithelial dysplastic lesions such as solar keratoses or HPV-induced squamous intraepithelial lesions (SIL) SCCIS commonly arises in epithelial dysplastic lesions such as solar keratoses or HPV-induced squamous intraepithelial lesions (SIL) Bowen’s disease Bowen’s disease Erythroplasia of Queyrat (glans penis, labia minora) Erythroplasia of Queyrat (glans penis, labia minora) Bowenoid papulosis (anogenital) Bowenoid papulosis (anogenital) Differential diagnosis: Nummuler eczema, psoriasis, seborrheic keratosis, solar keratosis, verruca vulgaris, condyloma acuminatum, superficial BCC, amelanotic melanoma, Paget’s disease Differential diagnosis: Nummuler eczema, psoriasis, seborrheic keratosis, solar keratosis, verruca vulgaris, condyloma acuminatum, superficial BCC, amelanotic melanoma, Paget’s disease Course and prognosis: Untreated SCCIS will progress to invasive SCC. Lymph node metastasis can occur without demonstrable invasion. Course and prognosis: Untreated SCCIS will progress to invasive SCC. Lymph node metastasis can occur without demonstrable invasion. Management: Topical 5-FU, imiquimod, cryosurgery, photodynamic therapy, surgical excision Management: Topical 5-FU, imiquimod, cryosurgery, photodynamic therapy, surgical excision

BASAL CELL CARCINOMA (BCC) Most common type of skin cancer. Most common type of skin cancer. Locally invasive, destructive, but there is very limited capacity to metastasize. Locally invasive, destructive, but there is very limited capacity to metastasize. SPT I and II with prolonged sun exposure SPT I and II with prolonged sun exposure Five clinical types: Nodular BCC, Ulcerating BCC, Sclerosing BCC, Superficial spreading BCC, Pigmented BCC Five clinical types: Nodular BCC, Ulcerating BCC, Sclerosing BCC, Superficial spreading BCC, Pigmented BCC Distribution: Isolated single lesion, >90% occur in the face. Superficial spreading (multicentric) BCCs occur on the trunk. Distribution: Isolated single lesion, >90% occur in the face. Superficial spreading (multicentric) BCCs occur on the trunk. Course and prognosis: BCC does not metastasize. Course and prognosis: BCC does not metastasize.

BCC (2) Differential diagnosis: All smooth papules like dermal nevus, trichoepitelioma, dermatofibroma, and others; if pigmented, superficial spreading and nodular melanoma; if ulceratedall nonpainful firm ulcers including SCC and a (extragenital) primary chancre of syphilis. Differential diagnosis: All smooth papules like dermal nevus, trichoepitelioma, dermatofibroma, and others; if pigmented, superficial spreading and nodular melanoma; if ulceratedall nonpainful firm ulcers including SCC and a (extragenital) primary chancre of syphilis. Management: Excision with primary closure, skin flaps or grafts, cryosurgery or electrosurgery, Mohs surgery, radiation therapy, topical 5-FU, imiquimod cream, photodynamic therapy. Management: Excision with primary closure, skin flaps or grafts, cryosurgery or electrosurgery, Mohs surgery, radiation therapy, topical 5-FU, imiquimod cream, photodynamic therapy.

KERATOACANTHOMA (KA) KA is a special lesion, a pseudocancer, occurring as an isolated nodule, usually on the face, and mimicking SCC. KA is a special lesion, a pseudocancer, occurring as an isolated nodule, usually on the face, and mimicking SCC. Rapid growth! Achieving a size of 2.5 cm within a few weeks. Rapid growth! Achieving a size of 2.5 cm within a few weeks. Etiology: HPV, UVR, chemical carcinogens (pitch, tar). Etiology: HPV, UVR, chemical carcinogens (pitch, tar). Differential diagnosis: SCC, hypertrophic actinic keratosis, verruca vulgaris. Differential diagnosis: SCC, hypertrophic actinic keratosis, verruca vulgaris. Spontaneous regression in 2 to 6 months or sometimes > 1 year. Spontaneous regression in 2 to 6 months or sometimes > 1 year. Management: Surgery Management: Surgery

CUTANEOUS T CELL LYMPHOMA (CTCL) CTCL is a term that applies to T cell lymphoma first manifested in the skin. CTCL is a term that applies to T cell lymphoma first manifested in the skin. The lymph nodes and internal organs become involved in the course of the disease. The lymph nodes and internal organs become involved in the course of the disease. CTCL is a malignancy of helper T cells (CD4+). CTCL is a malignancy of helper T cells (CD4+). All Mycosis Fungoides (MF) is CTCL, not all CTCLs are MF. All Mycosis Fungoides (MF) is CTCL, not all CTCLs are MF. Differential diagnosis: Atypical or refractory “ psoriasis”, “eczema”, and poikiloderma. Differential diagnosis: Atypical or refractory “ psoriasis”, “eczema”, and poikiloderma. Management: Phototherapy (PUVA, UVB), isotretinoin, s.c interferon, topical nitrogen mustard, topical potent steroid (early patch stage), electron-beam therapy, chemotherapy. Management: Phototherapy (PUVA, UVB), isotretinoin, s.c interferon, topical nitrogen mustard, topical potent steroid (early patch stage), electron-beam therapy, chemotherapy.